Overview

Effect of Ileal Bile Acid Transporter Inhibitor in Functional Constipation

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This is a single-center, randomized, parallel group, double-blind, placebo-controlled, dose response, pharmacodynamic and pharmacokinetic study evaluating the effects of A3309 on gastric, intestinal and colonic transit in patients with functional constipation.
Phase:
Phase 2
Details
Lead Sponsor:
Mayo Clinic
Michael Camilleri, MD
Collaborator:
National Center for Research Resources (NCRR)
Treatments:
Bile Acids and Salts